NCT02012062View on ClinicalTrials.gov

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

August 31, 2017

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

TPF neoadjuvant chemotherapy

DRUG

Concurrent chemotherapy with cisplatin during radiotherapy

DRUG

Concurrent nimotuzumab during radiotherapy

RADIATION

Radical radiotherapy

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
collaborator

Fujian Province Tumor Hospital

OTHER

collaborator

The First Affiliated Hospital of Xiamen University

OTHER

lead

Fudan University

OTHER

NCT02012062 - Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | Biotech Hunter | Biotech Hunter